Best Hodgkin's lymphoma doctors in Israel: TOP 19 doctors

Head of the Hematology Department at Sourasky Medical Center, leading the hospital's team for blood cancer care.

• Over 24 years of experience of experience as a hematologist
• Fellowship-trained at the prestigious Ronald O Perelman and Claudia Cohen Centre
• Specializes in blood cancers like Hodgkin's lymphoma
• Holds a medical degree from the University of Mysore

Performed several hundred stem cell transplants – Dr. Ram specializes in complex cases requiring this advanced procedure at Sourasky Medical Center.

• Board-certified in hematology, medical oncology, and internal medicine
• Authored over 30 scientific articles and a medical textbook chapter
• Completed his fellowship at New York Medical College and Westchester Medical Center
• Focuses exclusively on hematologic cancers

Dr. Ronit El Hasid has performed 300+ pediatric bone marrow and umbilical blood transplants, leading the department at Sourasky's Dana Dwek Children's Hospital.

• Specializes in pediatric oncology with focus on transplant procedures
• Published 50+ research papers and 40 conference reports
• Trained at City of Hope Hospital in Los Angeles
• Member of American and Israeli hematology societies

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Shapira works at Sourasky Medical Center's Bone Marrow Transplantation department – a critical treatment for Hodgkin's lymphoma.

• Has specialized in BMT since his senior role at Hadassah hospital
• Trained in internal medicine at the prestigious Hadassah medical center
• Graduated from the Hebrew University, one of Israel's top medical schools

Dr. Dror Levin is a leading pediatric hematology-oncology expert at Sourasky Medical Center, specializing in blood disorders and bone cancer in children.

• Director of children's hematology oncology department at Sourasky Medical Center
• Completed specialized training at Rizzoli Orthopaedic Institute – a global leader in bone oncology
• Member of Israel's pediatric hemato-oncology association ISPHO
• Coordinates multidisciplinary treatment for childhood sarcomas

Dr. Aviv brings 34 years of experience of dedicated experience treating blood cancers at the renowned Sourasky Medical Center (Ichilov).

• He is a specialist in oncohematology – the field of blood and bone marrow cancers
• He provides consultations online for remote evaluation
• His long tenure is at one of Israel's leading medical centers

Dr. Herishanu Yair has received multiple prestigious awards for his hematology research and clinical excellence at Tel-Aviv Sourasky Medical Center.

• Specializes in chronic lymphocytic leukemia treatment
• Recipient of the Klitzberg Oncology Award
• Member of both Israeli and American Hematology Associations
• Extensive training in hematology at top Israeli medical centers

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Ofer Spielberg is an oncohematologist specializing in blood cancers at Assuta Medical Center.

• Focuses exclusively on treating blood disorders and cancers
• Expert in the latest treatments for conditions like Hodgkin's lymphoma
• Provides personalized treatment plans for complex blood diseases

Professor Zila Zuckerman specializes in hematology and transplantology at Rambam Medical Center.

• Expert in treating blood cancers, including Hodgkin's lymphoma
• Focuses on advanced transplant techniques
• Works at one of Israel's leading medical centers

Specializing in radiotherapy and oncology, Dr. Karen Drumea offers expert care at Rambam Medical Center.

• Focuses on personalized treatment plans for Hodgkin's lymphoma
• Extensive experience in radiotherapy techniques
• Affiliated with Rambam Medical Center – a leading healthcare institution

Specialist in hematology with a focus on lymphomas, including Hodgkin's lymphoma, at Rambam Medical Center.

• Expertise in treating Hodgkin's lymphoma cases
• Specialized in hematology with a focus on lymphoproliferative diseases
• Associated with Rambam Medical Center, a leading hospital in Israel